AVAC Analyzer

Ultra-high sensitivity, several orders of magnitude better than conventional immunoassays — with remarkable throughput, multiplexing and a broad dynamic range.

avac technology

Optical reader & particle counter

The plasmonic nanoparticles are optically detected by measuring the weak scattering signal with proprietary dark-field micro-spectrophotometry.

Patents EP19382244, EP19382245

single particle digital counting

Count single molecules, one by one

As each plasmonic nanoparticle binds specifically to a biomarker of interest, by classifying and counting the different nanoparticles it is possible to quantify the amount of each biomarker immobilized on the substrate.

Pending EP19382245, EP19382244

performance

Femtogram-range sensitivity

High sensitivity in the femtogram range has been demonstrated for different biomarkers across therapeutic areas.

Oncology

PSA, biomarker for prostate cancer recurrence detection.

Cardiac diseases

Troponin I, biomarker of reference for Myocardial Infarction.

Infectious diseases

P24 biomarker for HIV detection.

Inflammation

Interleukin biomarkers (IL-10, IL-6, TNF-α).

Mecwins Total PSA Immunoassay

technical specifications

AVAC technical specifications

Spatial resolution0.7 µm (Diffraction-limited)

Reading / Analysis speedUp to 20,000 images per hour

Throughput96 samples in less than 5 minutes

Multiplexing capabilityUp to 5 biomarkers

User interfaceIntegrated 15” touch screen for all in- and outputs

ComputerFully integrated high-performance computer

Weight95 Kg

Dimensions (H x D x W)750 mm x 735 mm x 520 mm

get the details

Want the full AVAC specifications?

Talk to our team to learn how AVAC can fit your research or clinical workflow.